Franklin Resources Inc Reata Pharmaceuticals Inc Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $891,937 - $1.19 Million	11,259 Added 387.31%	14,166 $1.44 Million
Q1 2023 May 12, 2023	BUY	$30.85 - $93.17 $89,680 - $270,845	2,907 New	2,907 $264,000
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $6.58 Million - $12.4 Million	-338,767 Reduced 53.46%	294,889 $7.41 Million
Q2 2022 Aug 11, 2022	SELL	$20.71 - $36.5 $4.53 Million - $7.98 Million	-218,502 Reduced 25.64%	633,656 $19.3 Million
Q1 2022 May 13, 2022	SELL	$24.12 - $39.6 $2,532 - $4,158	-105 Reduced 0.01%	852,158 $27.9 Million
Q4 2021 Feb 11, 2022	SELL	$25.61 - $110.96 $4.41 Million - $19.1 Million	-172,035 Reduced 16.8%	852,263 $22.5 Million
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $36.4 Million - $52 Million	-363,662 Reduced 26.2%	1,024,298 $103 Million
Q2 2021 Aug 13, 2021	SELL	$78.27 - $151.29 $5.62 Million - $10.9 Million	-71,829 Reduced 4.92%	1,387,960 $196 Million
Q1 2021 May 13, 2021	SELL	$94.25 - $132.81 $201,506 - $283,947	-2,138 Reduced 0.15%	1,459,789 $146 Million
Q4 2020 Feb 10, 2021	BUY	$102.03 - $184.62 $6.97 Million - $12.6 Million	68,273 Added 4.9%	1,461,927 $181 Million
Q3 2020 Nov 12, 2020	BUY	$93.53 - $163.34 $5.67 Million - $9.89 Million	60,573 Added 4.54%	1,393,654 $136 Million
Q2 2020 Aug 13, 2020	BUY	$126.3 - $176.56 $16.6 Million - $23.2 Million	131,210 Added 10.92%	1,333,081 $213 Million
Q1 2020 May 13, 2020	SELL	$124.16 - $247.74 $5.12 Million - $10.2 Million	-41,260 Reduced 3.32%	1,201,871 $174 Million
Q4 2019 Feb 12, 2020	SELL	$74.57 - $217.92 $887,084 - $2.59 Million	-11,896 Reduced 0.95%	1,243,131 $254 Million
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $6.86 Million - $9.22 Million	96,297 Added 8.31%	1,255,027 $101 Million
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $14 Million - $17 Million	179,994 Added 18.39%	1,158,730 $109 Million
Q1 2019 May 14, 2019	BUY	$51.9 - $101.79 $904,980 - $1.77 Million	17,437 Added 1.81%	978,736 $83.7 Million
Q4 2018 Feb 12, 2019	BUY	$48.76 - $76.44 $4.99 Million - $7.82 Million	102,286 Added 11.91%	961,299 $53.9 Million
Q3 2018 Nov 13, 2018	BUY	$35.64 - $92.06 $21.2 Million - $54.6 Million	593,552 Added 223.59%	859,013 $70.2 Million
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $538 - $1,105	27 Added 0.01%	265,461 $9.28 Million
Q4 2017 Feb 14, 2018	BUY	$22.39 - $33.27 $344,626 - $512,091	15,392 Added 6.16%	265,434 $7.52 Million
Q3 2017 Nov 13, 2017	BUY	$26.29 - $31.88 $6.57 Million - $7.97 Million	250,042	250,042 $7.78 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account